Spotlight: Companies collaborate on computer model of multiple myeloma


GNS Healthcare, in collaboration with the Dana-Farber Cancer Institute and Mount Sinai School of Medicine, said today they will create a data-driven computer model of multiple myeloma--the second most common blood cancer in the U.S. that constitutes approximately one percent of all cancers. The model will help researchers discover novel therapies for the disease and to help them determine the best existing treatments for patients. It will be created using GNS's supercomputer-driven Reverse Engineering and Forward Simulation platform, which will reverse engineer network models from next-generation genetic sequencing, proteomic outcomes and other clinical data.